Mathilde Horn, MD, PhD

Because COVID-19 is associated with a risk of death and lack of effective treatments, patients are at risk of developing PTSD. This cohort study assessed the prevalence of PTSD...

This study aimed to estimate the prevalence of metabolic syndrome and its components in patients with treatment-resistant depression and determine correlations with sociodemographic, clinical, and treatment-related factors—read the article...